Evidence map›Paper›PMID 41873172›Full record

ArticleEpidemiology and infection2026

Burden of comorbid disease, treatment, and healthcare utilization among people with HIV: A retrospective, cross-sectional study from a large healthcare organization.

Clara Weil, Sivan Gazit, Arlene Nugent, Liza Murrison, Moshe Hoshen, Ana Pires Dos Santos, Itzchak Levy

Abstract read
In one paragraph

Article in Epidemiology and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clara WeilMaccabi Healthcare Services, Israel.
Sivan GazitMaccabi Healthcare Services, Israel.
Arlene NugentAbbVie Inc, USA.ORCID https://orcid.org/0009-0001-5817-7365
Liza MurrisonAbbVie Inc, USA.
Moshe HoshenMaccabi Healthcare Services, Israel.
Ana Pires Dos SantosAbbVie Inc, USA.
Itzchak LevyInfectious Diseases Unit, Sheba Medical Center, Israel.

Funding

AbbVie
6 · The paper itself

Abstract

This retrospective, cross-sectional study assessed the burden of HIV in Israel's Maccabi Healthcare Services in 2022. Among 2.6 million individuals assessed (lookback period: > 2 decades), 1973 PWH were identified and age-sex-matched (1:5) to 9,865 randomly selected controls without HIV. We compared sociodemographic, clinical characteristics, and healthcare resource utilization (HRU; Jan-Dec 2022) between people with and without HIV and characterized antiretroviral therapy (ART) treatment patterns among PWH (Jan-Dec 2022). Compared to controls, PWH had a higher lifetime prevalence (since 1988;

Indexed as

Cost of IllnessHIV InfectionsPatient Acceptance of Health CareAdultComorbidityCross-Sectional StudiesFemaleHumansIsraelMaleMiddle AgedRetrospective StudiesART use patternclinical burdencomorbiditiesgaps in carehealthcare utilizationHIVhospitalizationsMaccabi healthcare servicesreal-world evidence

Identifiers

PMID41873172
PMCPMC13100925

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.